Relative effectiveness and the European pharmaceutical market

被引：13

作者：

Jonsson, Bengt ^{[1
]}

机构：

[1] Stockholm Sch Econ, S-11383 Stockholm, Sweden

来源：

EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2011年 / 12卷 / 02期

关键词：

DRUGS;

D O I：

10.1007/s10198-011-0297-z

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

[No abstract available]

引用

页码：97 / 102

页数：6

共 50 条

[1] Relative effectiveness and the European pharmaceutical market
Bengt Jönsson
[J]. The European Journal of Health Economics, 2011, 12 : 97 - 102
[2] PRICE COMPARISON IN THE EUROPEAN PHARMACEUTICAL MARKET
Ressl, S.
Walter, E.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A406 - A407
[3] Outstanding Regulatory Aspects in the European Pharmaceutical Market
Panos Kanavos
Elias Mossialos
[J]. PharmacoEconomics, 1999, 15 : 519 - 533
[4] Outstanding regulatory aspects in the European pharmaceutical market
Kanavos, P
Mossialos, E
[J]. PHARMACOECONOMICS, 1999, 15 (06) : 519 - 533
[5] Policing the European pharmaceutical market's priorities
S. Garattini
V. Bertele'
[J]. European Journal of Clinical Pharmacology, 2000, 56 : 441 - 443
[6] IMPLICATIONS OF BREXIT ON EUROPEAN PHARMACEUTICAL MARKET ACCESS
Wang, G. D.
Macaulay, R.
[J]. VALUE IN HEALTH, 2018, 21 : S94 - S94
[7] POSSIBLE CONSEQUENCES OF BREXIT ON EUROPEAN PHARMACEUTICAL MARKET
Batraga, Anda
Kite, Matiss
Duboviks, Janis
Salkovska, Jelena
[J]. NEW CHALLENGES IN ECONOMIC AND BUSINESS DEVELOPMENT - 2020: ECONOMIC INEQUALITY AND WELL-BEING, 2020, : 54 - 64
[8] Policing the European pharmaceutical market's priorities
Garattini, S
Bertele', V
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) : 441 - 443
[9] European agencies discuss relative effectiveness
不详
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (04) : 259 - 259
[10] SHAPING THE FUTURE OF EUROPEAN HEALTH TECHNOLOGY ASSESSMENTS: EXPERIENCES OF THREE PHARMACEUTICAL JOINT RAPID RELATIVE EFFECTIVENESS ASSESSMENTS
Willemsen, A.
Estevao, S.
Dupree, R.
[J]. VALUE IN HEALTH, 2018, 21 : S199 - S200

← 1 2 3 4 5 →